As a freshman at Rice University, Anna Tutuianu ’23 knew she wanted to study how research in biomedicine and biomedical technologies intersected with society and history.
The Medical Humanities Research Institute at Rice aims to answer pressing questions through the Sawyer Seminar on the Comparative Study of Cultures, “Reimagining Technologies of Care: Racial Health Equity and Data Justice.”
A Rice-led multi-institutional research collaboration has won an award of up to $18 million over five years from the Advanced Research Projects Agency for Health (ARPA-H) to develop and validate a new system for improving tumor removal accuracy for two types of cancer: breast, and head and neck cancer.
Rice President Reginald DesRoches joined Rice360 Institute for Global Health Technologies Co-Director Maria Oden and Rice360 supporters on a trip to Africa marking significant milestones on the road to ending preventable newborn deaths in the sub-Saharan region.
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Rice University today announced that Motif Neurotech, a neurotechnology developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, closed an oversubscribed Series A financing round of $18.75 million.
The Newborn Essential Solutions and Technologies (NEST360) international alliance launches Phase 2 of its mission to reduce newborn mortality in sub-Saharan Africa with $65 million in funding from the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, The ELMA Foundation, and generous individual contributions.
Rice University recently launched its Medical Humanities Research Institute, the only institute in the United States and one of the few in the world that is solely dedicated to advancing translational research on human experiences of health and illness.
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.
Rice University today introduced the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.